Dyadic International Inc.

DYAI

Healthcare Biotechnology

Dyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024.

Revenue
−61.4%
EPS
n/m
Free cash flow
n/m
Total debt
+0.80%

Quarter to September 2026, against a year earlier

0.33 0.02 −5.71%
Market cap
$14.0M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
2/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

Ratios over time Q4 FY25 to Q3 FY26

Returns on capital

ROIC was 0.0% in Q3 FY26, the highest of these four quarters.

ROEROIC
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
ROE−397.8%−2826.8%522.6%−47310.8%
ROIC0.0%0.0%0.0%0.0%

Debt

It holds more cash than debt: net debt is −0.18× a year’s EBITDA.

Net debt / EBITDA
Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Net debt / EBITDA2.7×2.3×0.8×−0.2×

Cash cycle, in days

Customers pay in 0 days and suppliers are paid in 219. Suppliers fund 219 days of working capital.

Cash cycleDays to pay suppliersDays to be paid
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Cash cycle−1−4133−219
Days to pay suppliers13413894219
Days to be paid133971270

Per share, from Q4 FY25

Since Q4 FY25, per share: revenue has fallen 14.9%.

RevenueBook value
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue1.0×1.1×1.1×0.9×
Book value1.0×−0.3×−1.7×−1.8×
Sep '26 From the 10-Q filed 13 Nov Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
5.46 8.63 7.84 9.92
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(11.35) (18.04) (15.20) (17.32)
P/B ratio
0.00 0.00 0.00 24.88
EV/Sales
5.58 8.72 7.45 8.78
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(2.41) (4.41) (4.87) (4.67)
Current Ratio
1.69 1.65 2.42 2.68
Net Debt/EBITDA
— (0.18) 0.78 2.29
Debt/Equity
0.00 (2.11) (12.35) 4.08
Earnings Yield
(47.73%) (25.56%) (28.05%) (26.60%)
Free Cash Flow Yield
(42.42%) (22.91%) (19.52%) (18.96%)
Free Cash Flow per Share
(0.04) (0.05) (0.05) (0.05)
Book value per Share
(0.07) (0.07) (0.01) 0.04
Free Cash Flow
(1.48) (1.82) (1.96) (1.77)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 13 Nov 2026